1. Home
  2. BAK vs ALVO Comparison

BAK vs ALVO Comparison

Compare BAK & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Braskem SA ADR

BAK

Braskem SA ADR

HOLD

Current Price

$2.45

Market Cap

1.2B

Sector

Industrials

ML Signal

HOLD

Logo Alvotech

ALVO

Alvotech

HOLD

Current Price

$3.06

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAK
ALVO
Founded
1972
2013
Country
Brazil
Luxembourg
Employees
N/A
1460
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2002
N/A

Fundamental Metrics

Financial Performance
Metric
BAK
ALVO
Price
$2.45
$3.06
Analyst Decision
Hold
Buy
Analyst Count
2
4
Target Price
$4.40
$8.00
AVG Volume (30 Days)
2.1M
638.7K
Earning Date
05-12-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.02
$13.28
Revenue Next Year
$7.04
$18.63
P/E Ratio
N/A
$18.20
Revenue Growth
N/A
N/A
52 Week Low
$2.25
$2.94
52 Week High
$5.40
$9.94

Technical Indicators

Market Signals
Indicator
BAK
ALVO
Relative Strength Index (RSI) 40.11 35.84
Support Level $2.32 $2.99
Resistance Level $2.78 $3.94
Average True Range (ATR) 0.14 0.17
MACD 0.05 -0.03
Stochastic Oscillator 40.20 0.98

Price Performance

Historical Comparison
BAK
ALVO

About BAK Braskem SA ADR

Braskem SA is engaged in the manufacture, sale, import and export of chemicals, petrochemicals and fuels, as well as the production, supply and sale of utilities such as steam, water, compressed air and industrial gases. It also provides industrial services and is engaged in the production, supply and sale of electric energy and gas for its own use and use by other companies. Its segments include Brazil, USA and Europe; and Mexico. The Brazil segments delivered the majority of the revenue from the production and sale of chemicals; the supply of electricity and other inputs produced in these complexes to second-generation producers located in the petrochemical complexes; and the production and sale of PE, including the production of green PE made from renewable resources, and of PP.

About ALVO Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Share on Social Networks: